4-methoxyamphetamine has been researched along with carvedilol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, Y; Cho, JG; Hong, SN; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Lee, SR; Park, HW; Park, JC; Yun, NS | 1 |
| Bao, B; Fujiwara, H; Furukawa, Y; Hayano, M; Iwabuchi, M; Kadota, K; Kato, Y; Kimura, T; Kita, T; Mitsudo, K; Morimoto, T; Nakagawa, Y; Natsuaki, M; Nobuyoshi, M; Ozasa, N; Shiomi, H; Shizuta, S; Tada, T; Tazaki, J | 1 |
2 other study(ies) available for 4-methoxyamphetamine and carvedilol
| Article | Year |
|---|---|
Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Carbazoles; Carvedilol; Death; Disease-Free Survival; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Retrospective Studies; Simvastatin; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Carbazoles; Carvedilol; Combined Modality Therapy; Death; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Percutaneous Coronary Intervention; Propanolamines; Propensity Score; Registries; Treatment Outcome | 2013 |